维生素C对胰腺癌化疗相关贫血的疗效:随机对照试验的研究方案
Xinyue Wang1,2,3,4, Xinzhe Zhu1,2,3,4, Yi Liu1,2,3,4
1Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Xuhui District, No. 270, Dong'An Road, Shanghai, 200032, China.
Trials
|July 29, 2024
概括
这项研究调查了维生素C是否可以通过减少贫血和神经病变来改善晚期胰腺癌患者的化疗耐受性. 结果将评估其对生活质量和生存的影响.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 营养支持营养支持
背景情况:
- 晚期胰腺癌的治疗严重依赖于化疗,这会导致严重的副作用,如贫血和神经病变.
- 维生素C可以通过增强铁的吸收和缓解疼痛和麻木来改善化疗耐受性.
- 迄今为止还没有任何随机对照试验检查过维生素C在缓解晚期胰腺癌患者化疗毒性的作用.
研究的目的:
- 评估低剂量维生素C对接受化疗的转移性胰腺癌患者改善生活质量的影响.
- 评估维生素C在减轻化疗引起的副作用,包括贫血和神经病变方面的潜力.
主要方法:
- 一个前性,单中心,开放标签,随机对照试验.
- 招募至少100名患有晚期胰腺腺癌和远程转移的患者.
- 随机分配到单独的化疗或化疗加维生素C,以贫血率作为主要终点.
主要成果:
- 主要终点:贫血的发生率.
- 二级终点:三级神经病发病率,疼痛尺度变化,生活质量和整体存活率.
结论:
- 这项试验将提供关于维生素C在改善化疗中转移性胰腺癌患者生活质量的有效性方面的关键数据.
- 这项研究旨在确定维生素C是否可以作为一种有价值的辅助疗法,用于治疗化疗副作用.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
157
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
157
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
187
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
187
Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


